13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001892770
Total reported value
$189.2M
$189.2M
106 檔
75.5%
At the close of Q1 2024, Knott David M Jr disclosed equity holdings valued at approximately $189.2M, spread across 106 reported holdings.
During Q1 2024, Knott David M Jr's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including CLMTUSD, APO, CLOZ) accounted for 75.5% of total reported equity market value during Q1 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CLMTUSD | Calumet Specialty Products | Stock-Other | 22.73% | — | — | |
| 2 | APO | Apollo Global Management Inc | Stock-Financials | 8.95% | -0.85% | — | |
| 3 | CLOZ | Eldridge Bbb-b Clo ETF | ETF-Other | 6.82% | -0.06% | — | |
| 4 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 6.04% | +1.46% | — | |
| 5 | FTAI | FTAI Aviation Ltd. | Stock-Industrials | 5.95% | — | -41.18% | |
| 6 | LGND | Ligand Pharmaceuticals | Stock-Healthcare | 2.97% | — | — | |
| 7 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 2.94% | — | -62.55% | |
| 8 | ICLO | Invesco Aaa Clo F/r Note ETF | ETF-Other | 2.78% | — | — | |
| 9 | DCGO | Docgo Inc | Stock-Other | 2.75% | -0.27% | — | |
| 10 | PFE | Pfizer Inc | Stock-Healthcare | 2.43% | -0.13% | +153.79% | |
| 11 | JAAA | Janus Henderson Aaa Clo ETF | ETF-Other | 2.24% | -0.30% | +33.56% | |
| 12 | ARDX | Ardelyx Inc | Stock-Other | 2.13% | -0.03% | -40.22% | |
| 13 | OABI | Omniab Inc | Stock-Other | 2.12% | — | +1.56% | |
| 14 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 1.99% | — | +32.22% | |
| 15 | WEST | Westrock Coffee Co | Stock-Other | 1.73% | — | — | |
| 16 | ✓ | Inozyme Pharma Inc | Stock-Other | 1.53% | — | — | |
| 17 | JPM | Jpmorgan Chase & Co | Stock-Financials | 1.49% | -0.28% | — | |
| 18 | MFCSF | Medical Facilities CORP | Stock-Other | 1.44% | — | — | |
| 19 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 1.06% | -1.77% | EXIT | |
| 20 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 0.99% | — | — | |
| 21 | IMVT | Immunovant Inc | Stock-Other | 0.97% | — | +5644.11% | |
| 22 | CSX | Csx CORP | Stock-Industrials | 0.92% | — | — | |
| 23 | LKNCY | Luckin Coffee Inc - Adr | Stock-Other | 0.86% | — | — | |
| 24 | IRWD | Ironwood Pharmaceuticals Inc | Stock-Other | 0.85% | — | — | |
| 25 | CLOX | Eldridge Aaa Clo ETF | ETF-Other | 0.84% | — | — | |
| 26 | ESGRP | Enstar Group Limited - Deposita | Stock-Other | 0.82% | — | — | |
| 27 | DMRC | Digimarc Corporation | Stock-Other | 0.80% | — | — | |
| 28 | SNY | Sanofi-adr | Stock-Healthcare | 0.77% | — | -4.26% | |
| 29 | CVE | Cenovus Energy Inc | Stock-Energy | 0.67% | — | — | |
| 30 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 0.65% | — | +251.98% | |
| 31 | TVTX | Travere Therapeutics Inc | Stock-Other | 0.63% | +1.93% | +4.51% | |
| 32 | AB | Alliancebernstein Holding LP | Stock-Other | 0.60% | -0.18% | — | |
| 33 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 0.55% | -0.82% | — | |
| 34 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 0.54% | +0.11% | +433.33% | |
| 35 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 0.54% | +0.13% | — | |
| 36 | RHP | Ryman Hospitality Properties | Stock-Real Estate | 0.49% | +0.03% | — | |
| 37 | XERS | Xeris Biopharma Holdings Inc | Stock-Other | 0.47% | +0.78% | +54.68% | |
| 38 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 0.44% | — | — | |
| 39 | SYRS | Syros Pharmaceuticals Inc | Stock-Other | 0.44% | — | +191.52% | |
| 40 | ✓ | Stock-Other | 0.40% | — | +9.49% | ||
| 41 | EDIT | Editas Medicine Inc | Stock-Other | 0.37% | — | — | |
| 42 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.36% | — | — | |
| 43 | MDLZ | Mondelez International Inc-a | Stock-Consumer Staples | 0.35% | -0.01% | — | |
| 44 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.34% | +0.23% | -75.78% | |
| 45 | ABBV | Abbvie Inc | Stock-Healthcare | 0.32% | — | — | |
| 46 | KMB | Kimberly-clark CORP | Stock-Consumer Staples | 0.27% | — | — | |
| 47 | 6D8 | Dupont De Nemours Inc | Stock-Other | 0.27% | -0.10% | EXIT | |
| 48 | MSFT | Microsoft CORP | Stock-Tech | 0.24% | -0.03% | — | |
| 49 | CTVA | Corteva Inc | Stock-Materials | 0.24% | -0.01% | — | |
| 50 | DOW | Dow Inc | Stock-Materials | 0.23% | -0.01% | — |
According to official SEC Form 13F filings, Knott David M Jr reported a total U.S. public equity portfolio value of $189.2M across 106 disclosed positions in Q1 2024.
During Q1 2024, Knott David M Jr's top holdings by market value included CLMTUSD (22.7%)、APO (8.9%)、CLOZ (6.8%). The largest single position, CLMTUSD, represented 22.7% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q1 2024, Knott David M Jr made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.